2Duff SE,Li C,Garland JM,et al.CD105 is importment for angiogenesis:evidence and potential applications[J].FASEB J,2003,17 (9):984-992.
3Fonsatti E,Sigalotti L,Arslan P,et al.Erging role of endoglin (CD105) as a marker of angiogenesis with clinical potetial in human malignancies[J].Curr Cancer Drug Targets,2003,3(6):427-432.
4Fonsatti E,Vecchio DL,Altomonte M,et al.Endoglin:An accessory component of the TGF-beta-blinding receptor complex with diagnostic,prognostic,and bioimmunothe rapeutic potential in human maligniancies[J].J Cell Physical,2001,188(1):1-7.
5Mc Allister KA,Grogg KM,Johnson DW,et al.Endoglin,a TGF-βbinding protein of endothelial cells,is the gene for hereditary haemorrhagic telangictsia type[J].Nature Genet,1994,8(4):345-351.
6Miller DW,Graulich W,Karges B,et al.Elevated expression of endoglin,a component of the TGF-beta-receptor complex,correlates with prolifration of tumor endothelial cells[J].Int J Canaer,1999,81 (4):568-572.
7Li C,Guo B,Wilson PB,et al.Plasma a levels of soluble CD105 correlate with metastasis in patients with breast cancer[J].Int J Cancer,2000,89(2):122-126.
8Kumar S,Ghellal A,Li C,et al.Breast carcinoma:vascular density determined using CD105 antibody correlates with tumor prognosis[J].Cancer Res,1999,59 (4):856-561.
9Brewer CA,Setterdahl JJ,Li MJ,et al.Endoglin expression as a measure of microvessel density in cervical cancer[J].Obstet Gynecol,2000,96 (2):224-228.
10Tanka F,Otake Y,Yanagihara K,et al.Evaluation of angiogenesis in non-small cell cancer:comparison between anti-CD34 antibody and anti-CD105 antibody[J].Clint Cancer Res,2001,7(11):3410-3415.
二级参考文献13
1[1]Fonsatti E,Del Vecchil L,Altomonte M,et al.Endoglin:An accessory component of the TGF - beta - binding receptor - complex with diagnostic, prognostic, and bioimmunotherapeutic potenital in human malignancies[J] .J Cell physiol, 2001,188(1): 1.
2[2]Yamashita H,Ichijo H,Grimsby S,et al.Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor- β[J].The Journal of Biological Chemistry, 1994,269:1995.
3[3]Bodey B ,Jr Bodey B, Siegel SE,et al. Over- expression of endoglin (CD105) :a marker of breast carcinoma - induced neovescularization[J].Anticancer Research, 1998,18: 3621.
4[4]Takahashi N, Kavanishi Tabata R, Haba A, et al. Association of serum endoglin with matastisis in patients with colorectal,breast,and other solid tumours,and suppressive effect of chemotherapy on the serum endoglin[J].Clin Cancer Res,2001,7(3):524.
5[5]Li CG,Wang JM,Wilson PB, et al. Role of transforming growth factor beta 3 in lymphatic metastasis in breast cancer[J]. Intermational Journal of Cancer, 1998,79: 455.
6[6]Li CG,Guo BQ,Wilson PB,et al. Plasma levels of soluble CD105 correlate with metastasis in pations with breast cancer[J] .International Journal of Cancer,2000, 89: 122.
7[7]Wang JM, Kuamar S, Pye D, et al. A monoclonal antibody detests heterogeneity in vascular endothelium of tumors and normal tissue [J]. International Journal of Cancer, 1993,54: 363.
8[8]Wang JM, Kumar S, Pye D, et al. Breast carcinoma: comparative study of tumor vasculature using two endothelial cell markers[J] .Journal of the National Cancer Institute, 1994, 86: 386.
9[9]Kumar S,Ghellal A,Li C,et al. Breast carcinoma: Vescular density determined using CD 105 antibody correlates with tumor prognosis [J]. Cancer Research, 1999,59: 856.
10[10]Akagi K, Ikeda Y, Sumiyoshi Y, et al. Estimation of angiogenesis with anti - CD105 immunostaining in the process of colorectal cancer development[J]. Surgery, 2002, 131 (1): 109.
